NCT06985030

Brief Summary

In ophthalmic surgical practice, particularly for treating retinal detachment and macular hole disorders, vitrectomy procedures are routinely performed to remove the vitreous body followed by the injection of tamponade agents such as gaseous compounds (e.g., C3F8 or SF6) or silicone oil. These tamponade materials function by creating internal pressure against the retinal surface to facilitate reattachment. A critical determinant of surgical success in these cases is postoperative head positioning (prone posturing), as improper alignment may compromise the tamponade effect. At the investigators' institution, participants undergoing such procedures are prescribed a strict prone position regimen for 7 consecutive postoperative days. This facedown positioning protocol aims to optimize interfacial contact between the tamponade agent and retinal tissue. However, conventional clinical practice faces a significant limitation: the inability to objectively verify patient compliance with prescribed postural guidelines outside clinical settings. Subjective patient reporting and intermittent clinical observations prove insufficient for quantifying adherence levels. To address this critical gap in postoperative monitoring, the investigators propose implementing a novel electronic monitoring system integrated into therapeutic eye patches. This advanced device incorporates a miniaturized triaxial gyroscopic sensor array capable of continuously tracking cephalo-cervical orientation with high angular resolution. The system features complete electrical isolation from ocular tissues while maintaining sterility. Data acquisition occurs through a microSD card (capacity: 16GB) that logs positional parameters at 0.2Hz sampling frequency, creating comprehensive temporal records of head movement patterns.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 28, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 24, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 22, 2025

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2025

Completed
Last Updated

May 22, 2025

Status Verified

March 1, 2025

Enrollment Period

6 months

First QC Date

March 24, 2025

Last Update Submit

May 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Compliance of head positioning

    1. % time of right head positioning time (%) 2. % time of applying eye patch time (%) 3. Averaged deviation from instructed positioning (degree) 4. % time of cotact between tamponade and retinal tear or macular hole (%) 5. Questionaire (Visual Analogue Scale) : * pain, disability in daily life (dressing, eating, sleeping, washing, households)

    From enrollment to 7 days after surgery

Secondary Outcomes (1)

  • Baseline demographic and ocular characteristics

    At enrollment

Interventions

Small pcb with gyroscope and lithium polymer battery embedded eyeshield will be distributed right after surgery

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients who get vitrectomy with gas or silicone oil tamponade followed by positioning prescription

You may qualify if:

  • Patients who get vitrectomy

You may not qualify if:

  • Patients who cannot maintain positioning due to their physical disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital, dep. of Ophthalmology

Seoul, 03080, South Korea

Location

MeSH Terms

Conditions

Retinal DetachmentRetinal Perforations

Condition Hierarchy (Ancestors)

Retinal DiseasesEye Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2025

First Posted

May 22, 2025

Study Start

November 28, 2024

Primary Completion

May 31, 2025

Study Completion

June 7, 2025

Last Updated

May 22, 2025

Record last verified: 2025-03

Locations